Genomic Health Inc. GHDX -1.67% said it anticipates generating net income of $5 million to $8 million for 2012. However, this would be before an incremental loss of up to $8 million incurred as a result of setting up a new subsidiary, the Redwood City, Calif.-based company said. The subsidiary will be established to make “clinically relevant genetic information available to physicians and patients” starting in 2013, Genomic Health said. It plans to invest up to $20 million in the unit over the next two years. The company also pegged full-year revenue in a range of $230 million to $240 million, compared to $206.1 million for 2011, and projected it would deliver 75,000 to 77,000 Oncotype DX test results during 2012, up from more than 66,600 last year.
How arrogant I am,a small player a _____ If you are not long and strong you are wrong.A short position is evil,,,you have heard them all. No need to go into my background for anyone can post anything,so I will just take issue with some erroneous posts about trading this thinly traded stock "without moving it"----------- that's blch1t I have traded over 100k worth in a day more than a few times over the last year and a half with GHDX.Depending what the MMs want to do that particular day you can always move your shares.The short interest has added plenty of liquidity to trade.
The little boys are jealous,I remain positive on the company and probably know more about GHDX than boys who think rank outs mean something.I'll trade and make money,more than any buy and hold ever will.I am not only buying.----I'm adding on the dip here.The chart continues to show a intact uptrend.